Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$25.98 -0.16 (-0.63%)
As of: Oct 20, 2026 · 2:06 PM EDT

Amphastar Pharmaceuticals (AMPH) Liabilities and Shareholders Equity (2013 - 2026)

Updated

Amphastar Pharmaceuticals (AMPH) reported Liabilities and Shareholders Equity of $1.74 billion for Q2 2026, up 8.0% from $1.62 billion a year earlier and up 5.8% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends

At the end of FY2025, Amphastar Pharmaceuticals posted Liabilities and Shareholders Equity of $1.63 billion, up 3.3% from FY2024.

  • Liabilities and Shareholders Equity has increased for 12 consecutive years, with a five-year compound annual growth rate of 20.9% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $1.58 billion in FY2024 (+4.3%), $1.51 billion in FY2023 (+103.9%), $741.99 million in FY2022 (+10.5%) and $671.53 million in FY2021 (+6.4%).
  • The Q2 2026 figure ranks as the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2013.
  • Year over year, Liabilities and Shareholders Equity has now increased in each of the last seven quarters, with growth averaging 4.5% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Liabilities and Shareholders Equity ranged from 0.0% (Q3 2024) to 112.6% (Q3 2023).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.65 billion (Q1 2026), $1.63 billion (Q4 2025) and $1.67 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,153.07 Bn 1,121.65 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 624.88 Bn 543.40 Bn 17.26 Bn 201.06 Bn
3 AbbVie 514.08 Bn 487.19 Bn 12.70 Bn 135.12 Bn
4 Merck 366.14 Bn 320.52 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 297.86 Bn 261.85 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.47 Bn 235.16 Bn 12.86 Bn 115.83 Bn
7 Amgen 235.14 Bn 190.54 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.12 Bn 168.32 Bn 6.22 Bn 49.36 Bn
9 Pfizer 172.20 Bn 118.84 Bn 10.94 Bn 201.13 Bn
10 Amphastar Pharmaceuticals 1.13 Bn -7.44 Mn 93.47 Mn 1.74 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.74 Bn
Mar 31, 2026 1.65 Bn
Dec 31, 2025 1.63 Bn
Sep 30, 2025 1.67 Bn
Jun 30, 2025 1.62 Bn
Mar 31, 2025 1.63 Bn
Dec 31, 2024 1.58 Bn
Sep 30, 2024 1.55 Bn
Jun 30, 2024 1.49 Bn
Mar 31, 2024 1.57 Bn
Dec 31, 2023 1.51 Bn
Sep 30, 2023 1.54 Bn
Jun 30, 2023 1.38 Bn
Mar 31, 2023 773.66 Mn
Dec 31, 2022 741.99 Mn
Sep 30, 2022 726.70 Mn
Jun 30, 2022 723.72 Mn
Mar 31, 2022 716.24 Mn
Dec 31, 2021 671.53 Mn
Sep 30, 2021 651.68 Mn
API Access

Amphastar Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=AMPH&period=max&api_key=YOUR_API_KEY